O'SullivanMJaroszJMMartinRJDeasyNPowellJFMarkusHS: MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology2001; 56: 628–34.
6.
AuerDPPutzBGosslCElbelGKGasserTDichgansM: Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology2001a; 218: 443–51.
7.
MarkusHSMartinRJSimpsonMA. Diagnostic strategies in CADASIL. Neurology2002; 59: 1134–8.
8.
AdamsRJ: Stroke prevention and treatment in sickle cell disease. Arch Neurol2001; 58: 565–8.
9.
AdamsRMcKieVNicholsF. The use of transcranial ultrasonography to predict stroke in sickle cell disease. New Engl J Med1992; 326: 605–10.
10.
AdamsRJMcKieVCHsuL. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New Engl J Med1998; 339: 5–11.
11.
SebastianiPRamoniMFNolanVBaldwinCTSteinbergMH: Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet2005; 37: 435–40.
HankeyGJEikelboomJWvan BockxmeerFMLofthouseEStaplesNBakerRI: Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke2001; 32: 1793–9.
14.
RolfsABottcherTZschiescheM. Prevalence of Fabry disease in patients with cryptogenic stroke: A prospective study. Lancet2005; 19: 1794–6.
15.
HassanAHuntBO'SullivanM. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain2004; 117: 212–9.
16.
CasasJPBautistaLESmeethLSharmaPHingoraniAD: Homocysteine and stroke: Evidence on a causal link from Mendelian randomisation. Lancet2005; 365: 224–32.
17.
DichgansMMarkusHS: Genetic association studies in stroke: Methodological issues and proposed standard criteria. Stroke2005; 36: 2027–31.
18.
TalmudPJHumphriesSE: Gene: Environment interactions and coronary heart disease risk. World Rev Nutr Diet2004; 93: 29–40.
19.
Jerrard-DunnePSitzerMRisleyPBuehlerAvon KeglerSMarkusHS: Inflammatory gene-load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke2004; 35: 2438–43.
20.
MarkusHSLabrumRBevanS. Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke2006; 37: 2253–9.
21.
HelgadottirAManolescuAThorleifssonG. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet2004; 36: 233–9.
22.
DwyerJHAllayeeHDwyerKM. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. New Engl J Med2004; 350: 29–37.
23.
HakonarsonHThorvaldssonSHelgadottirA. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: A randomized trial. JAMA2005; 293: 2245–56.
24.
DoveA: The SNPs are down: Genotyping for the rest of us. Nature Methods2005; 12: 989–93.
25.
KleinRJZeissCChewEY. Hoh J complement factor H polymorphism in age-related macular degeneration. Science2005; 308: 385–9.